GH vs. IONQ
GH (Guardant Health, Inc.) and IONQ (IonQ, Inc.) are both stocks. GH operates in Diagnostics & Research (Healthcare), while IONQ operates in Computer Hardware (Technology). Over the past 5 years, GH returned 0.19%/yr vs 41.98%/yr for IONQ. At a 0.37 correlation, their price movements are largely independent.
Performance
GH vs. IONQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GH achieves a 26.13% return, which is significantly lower than IONQ's 29.98% return.
GH
- 1D
- -2.24%
- 1M
- 8.31%
- YTD
- 26.13%
- 6M
- 27.13%
- 1Y
- 162.17%
- 3Y*
- 53.63%
- 5Y*
- 0.19%
- 10Y*
- —
IONQ
- 1D
- 3.13%
- 1M
- -8.36%
- YTD
- 29.98%
- 6M
- 8.28%
- 1Y
- 44.50%
- 3Y*
- 83.95%
- 5Y*
- 41.98%
- 10Y*
- —
GH vs. IONQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GH Guardant Health, Inc. | 26.13% | 234.34% | 12.94% | -0.55% | -72.81% | -22.39% |
IONQ IonQ, Inc. | 29.98% | 7.42% | 237.13% | 259.13% | -79.34% | 50.11% |
Correlation
The correlation between GH and IONQ is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2021 | 0.37 |
The correlation between GH and IONQ shifts across timeframes, from 0.20 (1 year) to 0.38 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
GH:
$16.91B
IONQ:
$21.65B
GH:
-$3.40
IONQ:
$0.86
GH:
15.19
IONQ:
100.18
GH:
$1.08B
IONQ:
$187.12M
GH:
$701.01M
IONQ:
$71.25M
GH:
-$411.42M
IONQ:
$405.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GH vs. IONQ — Risk / Return Rank
GH
IONQ
GH vs. IONQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Guardant Health, Inc. (GH) and IonQ, Inc. (IONQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GH | IONQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.33 | ||
| Sortino ratioReturn per unit of downside risk | +2.21 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.15 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 4.95 | 0.66 | +4.29 |
| Martin ratioReturn relative to average drawdown | 12.27 | 1.19 | +11.08 |
Loading charts...
Drawdowns
GH vs. IONQ - Drawdown Comparison
The maximum GH drawdown since its inception was -91.03%, roughly equal to the maximum IONQ drawdown of -90.00%. Use the drawdown chart below to compare losses from any high point for GH and IONQ.
Loading charts...
Drawdown Indicators
| GH | IONQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.03% | -90.00% | -1.03% |
Max Drawdown (1Y)Largest decline over 1 year | -32.98% | -67.61% | +34.63% |
Max Drawdown (3Y)Largest decline over 3 years | -59.79% | -67.61% | +7.82% |
Max Drawdown (5Y)Largest decline over 5 years | -87.84% | -90.00% | +2.16% |
Current DrawdownCurrent decline from peak | -28.07% | -28.96% | +0.89% |
Average DrawdownAverage peak-to-trough decline | -51.50% | -50.80% | -0.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.27% | 37.44% | -24.17% |
Volatility
GH vs. IONQ - Volatility Comparison
The current volatility for Guardant Health, Inc. (GH) is 13.07%, while IonQ, Inc. (IONQ) has a volatility of 30.22%. This indicates that GH experiences smaller price fluctuations and is considered to be less risky than IONQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GH | IONQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.07% | 30.22% | -17.15% |
Volatility (6M)Calculated over the trailing 6-month period | 38.12% | 68.14% | -30.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.29% | 93.98% | -35.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.65% | 100.68% | -33.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.23% | 97.47% | -29.24% |
Dividends
GH vs. IONQ - Dividend Comparison
Neither GH nor IONQ has paid dividends to shareholders.
Financials
GH vs. IONQ - Financials Comparison
This section allows you to compare key financial metrics between Guardant Health, Inc. and IonQ, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GH and IONQ have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IONQ has higher volatility (30.22%) compared to GH (13.07%). In terms of maximum drawdown, GH dropped -91.03% vs IONQ's -90.00%.
GH currently has the higher Sharpe Ratio (2.80 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GH and IONQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer